476 related articles for article (PubMed ID: 10501315)
1. Treatment of pneumococcal pneumonia.
Pallares R
Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
[TBL] [Abstract][Full Text] [Related]
2. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
4. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
Sánchez C; Armengol R; Mir I; Lite J; Garau J
Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
[TBL] [Abstract][Full Text] [Related]
5. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F
N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
[TBL] [Abstract][Full Text] [Related]
8. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
Soriano F
Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
[No Abstract] [Full Text] [Related]
10. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
12. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
13. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
15. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
Peterson LR
Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
[TBL] [Abstract][Full Text] [Related]
16. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia due to resistant Streptococcus pneumoniae.
Täuber MG
Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF
N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
